 | | | | U.S. intelligence agencies are examining reports that researchers at a Chinese virology laboratory were seriously ill in 2019 a month before the first cases of COVID-19 were reported, according to U.S. government sources who cautioned that there is still no proof the disease originated at the lab. | | | | | | Mexico Foreign Minister Marcel Ebrard said on Monday the country will soon begin phase three trials for COVID-19 vaccines by France's Sanofi and China's Walvax. | | | | | | The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. | | | | | | Algeria will impose strict health measures on passengers when it partially resumes international flights next month, the prime minister's office said on Monday. | | | | | | French hospitals recorded 66 COVID-19 deaths over the last 24 hours, the health ministry said on Monday, a further decline from the previous day's seven-month low of 70. | | | | | | The U.S. State Department on Monday urged against travel to Japan due to a new wave of COVID-19 infections, issuing a "Do Not Travel" advisory just two months before the Tokyo Olympics are set to take place. | | | | | | The United States last week reported the lowest number of new COVID-19 cases in nearly a year, with new infections dropping 26% from the previous seven days to just under 180,000, according to a Reuters analysis of state and county data. | | | | | | White House Press Secretary Jen Psaki said on Monday the United States could not confirm a Wall Street Journal report on the origins of COVID-19 and needed more information. | | | | | | Russia's Sputnik V COVID-19 vaccine is highly effective in fighting off and neutralizing the aggressive coronavirus variant first discovered in Brazil, according to Russia's Direct Investment Fund (RDIF) and a study conducted by researchers in Argentina. | | | | | | Centessa Pharmaceuticals Plc, the newly formed biopharma company backed by private equity firm General Atlantic, said on Monday it was aiming for a valuation of up to $1.7 billion in its initial public offering in the United States. | | | | | |
